In approaching this subject I have taken the liberty of giving it a rather liberal interpretation. I have not considered it my task to present a thoroughly documented review of the clinical results that have been reported in the vast and rapidly growing literature on the medical uses of the currently available antibiotics. It has seemed to me more suitable to give some general views and interpretations concerning current clinical uses of available antibiotics, first from the point of view of the individual agents and then with respect to their application to special diseases or in special situations. There is still left too wide a range of topics, so that, of necessity, only a few can be touched upon, and these only briefly. For more complete reviews of recent literature with adequate documentation and interpretation the reader is referred to Dr. Welch's book, in its forthcoming revision, and to the papers in the Annual Reviews of Microbiology for the years 1951, 1952, and 1953 by Herrell, Kirby, and Heilman. respectively.
In recent years it has become abundantly clear that new antimicrobial agents with activity which clearly overlaps or even closely parallels that of previously available agents can achieve wide acceptance and use in a rather brief time. Moreover, new agents and some which had previously been unpopular, or generally thought to be inferior or even discarded, can gain acceptance and, in some instances, even supersede others which have been regarded as of proved efficacy or superiority. This phenomenon is of considerable significance in relation to the understanding of current usages and is open to diverse interpretations.
First and foremost, one is confronted with the fact that by far the greatest proportion of the antibiotics that are used to-day are prescribed for conditions which have no clear relation to the efficacy of those agents. Indeed, in most instances the relative efficacy of the various agents for the particular uses to which they are put has not been clearly assessed, and in fact is usually difficult or impossible to evaluate. In the -choice of agents for most prophylactic purposes or for the treatment of mild and relatively unimportant infections, or for the combined use of multiple agents, preference is likely to be shown to those which are considered relatively harmless rather than to be superior. When any *Based on a paper presented on October 28 at the Antibiotics one agent is used freely over long periods and without proper indications, there almost inevitably comes an awareness of the sensitizing and other potential toxic effects of the agent so used and also of its inadequate therapeutic effectiveness. Under such circumstances it seems easier to shift to a new one rather than to become more selective with respect to the patients to be treated and agents to be used. Investigators who conduct the initial clinical trials of new antibiotics in their anxiety to discover and reveal as much as possible about the potential usefulness of these agents often publish their results prematurely. Although they may present these results accurately and interpret the findings with the greatest caution, their findings and the conclusions are often grossly exaggerated and misinterpreted or given new meanings, both by readers who wish to justify some particular applications and by manufacturers who wish to exploit their products. Such preliminary trials can generally be expected to uncover only the broad outlines of the field of usefulness of a new agent. More definitive evaluations, concerning both the absolute and the relative efficacy and toxicity, require prolonged and controlled clinical trials, and such trials have only rarely been made before the use of a new and promising agent has already been widely adopted.
Real or apparent increases in clinical resistance have been encountered in infections caused by staphylococci, Pseudornonas, Proteus, and some coliform organisms (and possibly also enterococci and non-haemolytic streptococci); these have obviously offered a legitimate field for new antimicrobials or for changing the emphasis in the use of the available ones. Such changes, however, have frequently, and sometimes unavoidably, been carried beyond the proper and proved indications. 
Penicillin
It seems almost commonplace to mention that penicillin is still the most effective and least toxic agent available for the treatment of most infections due to organisms which are moderately or highly sensitive to it in vitro. Some of its usefulness, however, has been reduced by excessive and unnecessarily widespread usage over the past few years, which has resulted in the sensitization of large numbers of individuals and, in the case of the staphylococcus, by the gradual elimination of sensitive strains. The general recognition of the increase in resistance of pathogenic staphylococci to penicillin in all hospitals and communities where this agent is used very extensively has also raised the obvious question of whether penicillin might be losing some of its effectiveness in other infections for which it is generally employed. The tendency to prescribe dosages which appear inordinately high and ever increasing in relation to the previously known sensitivity of the strains of organisms in the diseases for which it is being used has inevitably given the impression of diminished efficacy; it is more likely, however, that this has little or no relation to any established factors other than fashion and usage.
Thus far, there appears to be no evidence of any decreased activity in vitro among recently isolated strains of organisms, at least of the more sensitive species-namely, gonococcus, pneumococcus, and group A streptococcus. Likewise, there seems to be no change in the clinical efficacy of penicillin against infections caused by these organisms. There also has been no significant change in the effectiveness of penicillin in the treatment of syphilis since the use of purified crystalline penicillin G was standardized. In subacute bacterial endocarditis, on the other hand, it is possible that some decrease in efficacy of penicillin is responsible for the present need for large doses. This, too, may have its origin in the widespread use of penicillin, which may have resulted in a general, though not so marked, reduction in the sensitivity of strains of the viridans group of streptococci, which are so universally present as part of the normal flora of the mouth and which are also the major cause of this disease.
Little can be said about the relative effectiveness of the various new forms of penicillin. L-Ephenamine penicillin G ("compenamine") and penicillin 0 (allylmercaptyl penicillin G), with its repository form chloroprocaine penicillin 0, are presumed to be equivalent in their therapeutic effectiveness to penicillin G and to procaine penicillin; although this has not been conclusively proved, there is no evidenc_ to the contrary. In the case of penethamate (the hydriodide of diethylaminoethyl ester of penicillin G, "neo-penil ") conclusive proof is still lacking for anv superiority in its therapeutic effectiveness over penicillin G or procaine penicillin in conditions in which a specific localization might be considered advantageous. 
Streptomycin
Although streptomvcin remains the major mainstay in the treatment of tuberculosis, two important features have led to renewed interest in this agent and an increase in its systemic use in many non-tuberculous infections. One is the use of smaller doses (1 or 2 g. a day) and shorter courses, which mtinimize the occurrence of the major toxic effects of this antibiotic on the eighth nerve; the other is the use of strentomycin in combination with other agents, particularly with large doses of penicillin, which has resulted in an increase in its effectiveress against relatively riesistant Gram-positive organisms, coupled with a reduction in the rate and degree of emergence of streptomycinresistant variants. The latter usage is best typified in the treatment of bacterial endocarditis due to organisms which are onlv slightly sensitive to either penicillin or streptomycin separately. It is important, however, to avoid the use of streptomycin alone in such cases, lest rcsistant variants emrerge rapidly during such use and subsequently interfere with the successful application of the combined therapy.
The rapid bactericidal action of streptomycin has, in our experience, been most helpful in the earlv acute stage of severe infections with Gram-negative bacilli, particularly in Friedl5nder's pneumonia. although the character of the necrotizing lesion in the latter has militated against its continued effectiveness and against its success in comoletely eliminating the organiqms. Resort must then be had to other antibiotics to which the residual organisms are sensitive. Streptomycin is still useful either alone or together with other antimicrobial agents in the treatment of meningitis, infections of the urinary tract, and other severe infections with susceptible organisms; also, used together with penicillin and/or sulphonamides, it still has an important place in the prevention and treatment of generalized peritonitis. The importance of alkalinization of the urine in enhancing the effectiveness of streptomycin in the treatment of urinary tract infections cannot be overemphasized.
A serious question may be raised whether the generally prevailing use of dihydrostreptomycin in preference to streptomycin has a sound basis. It now seems clear that dihydrostreptomycin tends to produce a predominantly auditory-nerve damage which may be insidious and delayed in its onset and usually is irreversible; streptomycin, on the other hand, gives rise predominantly to vestibular dysfunction, which may be recognized early, and at that stage, if the treatment has stopped, may be reversible. Any difference in antimicrobial activity of the two agents in vitro or in experimental animals is probably slight, but it appears to be predominantly in favour of streptomycin, while no appreciable difference has been demonstrated in the clinical activity of these two forms. Is it not, therefore, more appropriate to consider streptomycin the first choice in therapy as between these two forms, with dihydrostreptomycin reserved for continuing the treatment when it is imperative to do so with evidence of sensitization, or possibly after symptoms of vestibular damage are first recognized ? It is possible, however, that this problem may be resolved bx the combined use of the two forms if present indications of the much lower toxicity of this combination are more firmly established.
The Tetracyclines Now that the chemical kinship of " aureomycin " and "terramycin," which had long been suspected, has been fully established, it is appropriate to consider these two agents together and also to include the third one, tetracycline, which chemically has been divested of the distinguishing portions of the structure of each of the other two. Preliminary observations in our laboratory and clinic would point to a very close similarity in the antibacterial action of these three analogues int vitro and in vivo. The differences which have been noted in vitro seem to be related chiefly to the instability of aureomycin outside of the body, and the clinical differences appear to be related primarily to the lower toxicity of tetracycline.
The relative clinical efficacy of tetracycline may be extremely difficult to evaluate, just as we have found great difficulty in establishing any clear and overall differences in efficacy between aureomycin and terramycin. On the other hand, there seems little doubt that in isolated individual patients, there appears to be a gross and distinguishable difference in activity between the two latter agents, favouring the one or the other, and there may also prove to be such a difference in occasional patients or infections with respect to tetracycline and either or both of the other chemically related substances. From the point of view of toxicity, only the untoward gastro-intestinal effects lend themselves to comparison. Data thus far available would indicate that the use of tetracycline is accompanied by a significantly lower incidence of gastro-intestinal symptoms than is the use of aureomycin in comparable doses and in similar patients. Terramycin, in our clinic, has regularly produced an appreciably greater incidence of gastrointestinal symptoms than aureomycin, particularly the diarrhoeas associated with displacement of the faecal flora by resistant staphylococci.
The tetracycline antibiotics are still highly effective against infections with a wide variety of Gram-positive and Gramnegative bacteria, including many types of bacterial meningitis. In our experience and in many other hospitals intravenous aureomycin has also proved to be the most effective single antimicrobial agent in the treatment of acute diffuse peritonitis. One interesting phenomenon that has been noted is the apparently striking efficacy of intravenouis aureomycin in the treatment of peritonitis due to Salmonella typhosa and resulting from perforations of the bowel or of the gallbladder complicating chloramphenicol-treated typhoid fever.
The tetracyclines are highly effective against all rickettsial infections, and they appear to be the most effective agents available against the psittacosis-lymphogranuloma-trachoma group of organisms. The effectiveness of all antibiotics against trachoma, however, has recently been questioned in some quarters. The popular misconception about the efficacy of these agents against "viruses'" had led to many conflicting reports on their use in many diseases known or presumed to be of viral aetiology. In general, it is probably fair to state that no clear-cut proof of the effectiveness of these agents in uncomplicated viral infections has yet been brought forth. Moreover, although most workers have felt that the efficacy of aureomycin in the treatment of cases of primary atypical pneumonia of the type associated with cold agglutinins has been proved, some doubts have also been raised in this regard.
There is, however, clear evidence of a decreasing efficacy of aureomycin and terramycin in the treatment of some staphylococcal infections this is associated with an increased incidence of staphylococci resistant to these agents. The decrease in effectiveness, however, seems to be limited primarily, or perhaps entirely, to nosocomial infections with staphylococci or to such infections acquired during the course of treatment with one of these agents, and they may in fact be confined to hospitals in which either or both of these agents have been very widely used. There is also a suggestion of a decrease in the effectiveness of the tetracyclines in the treatment of infections with some coliform organisms, particularly Aerobacter aerogenes.
Chloramphenicol
The clinical activity oi this agent overlaps most of the range of infections which are favourably influenced by the tetracyclines. Chloramphenicol appears to be appreciably less effective against infections with Gram-positive organisms and probably also against the psittacosis-lympho- Occasional successes have also been reported in meningitis and brain abscess due to similar organisms: in these conditions it is said to be devoid of local irritation, thus permitting topical application, intrathecally, intraventricularly, and into brain abscesses. The local irritation from intramuscular injection, however, may be quite marked, but this is minimized by including procaine with the diluent and by limiting individual injections to 25,000 units or less. The nephrotoxicity of bacitracin, which is inherently related to its activity, is generally transient it has also been limited to some extent by improvements in manufacture, but chiefly by keeping the average daily dose in adults down to 100,000 units or less. maintaining the urine at a neutral or slightly alkaline pH, and avoiding systemic treatment or using it with great caution in patients who already have reduced renal function.
Polymyxin B, likewise, has found special uses, locally and systemically, in the treatment of infections with strains of PseudoMlonas and other Gram-negative bacilli which are resistant to other forms of treatment. As with bacitracin, the nephrotoxicity has been either avoided or transient, or kept at a minimum by proper dosage, and in children the drug has not been much of a problem when properly used. The local irritation and slight fever from intramuscular injections has been found to be much lower in purified preparations of polymyxin B and more recently in preparations of polymyxin E. The paraesthesias, however, are still a particularly prominent feature of treatnrent in adults, but do not seem to be very important in infants and children.
Neomycin is probably the most toxic of these agents when used systemically, producing renal and auditory damage with sufficient frequency and severity to justify its use in this manner only under circumstances which warrant great risks. The toxicity is minor when the dose is kept at I g. a day and given for brief periods. When so used, it may be of value in some infections with organisms sensitive to this antibiotic, but considered to be resistant to other agents.
The major uses of bacitracin and also of polymyxin and neomycin, at present, seem to be their local application in the treatment of infected wounds and dermatological lesions. Their low irritating and sensitizing potential when used in this manner has made them especially suited for these purposes.
Moreover, such usage is particularly appropriate because of the higher sensitizing potential of most of the antibiotics that are more com monly used for systemic therapy. 
Meningococcal Infections
Meningococcal infections appear destined to increase in prevalence during the coming years. There is no evidence to indicate that the sulphonamide drugs, particularly sulphadiazine, have as yet been displaced as the most effective agents in the treatment of infection with this organism. The occurrence of sulphonamide-resistant strains, if they have been encountered, must be extremely rare. However, the general tendency of physicians to inject procaine penicillin, or some other repository form of penicillin, into all patients with fever may result in an increase in the number of failures in the treatment of this disease. Moreover, although the use of huge intramuscular doses of soluble preparations of penicillin may be effective in the treatment of meningococcal meningitis, such a regimen hardly seems warranted and can hardly be recommended as the treatment of choice if the sulphonamides are equallv or more effective.
Hormone Therapy
In connexion with the problem of meningococcal infections, any increase in their prevalence is inevitably associated with an increase in the occurrence of cases of the so-called Waterhouse-Friderichsen syndrome. Since the adrenal hormones have been generally accepted as an integral part of the treatment of this condition, it seems appropriate to raise the question of the use of adrenal hormones in infection. This subject was reviewed by Thomas,' and more recently by Kass and Finland.2 Among certain groups of clinicians interested in this subject there are apparently widely divergent views which, because of the paucity of adequately controlled data, are quite difficult to reconcile. There are those who feel that such hormones should be given to all patients with severe infections in order to hasten the symptomatic recovery while awaiting the more lasting and curative effects of antibiotics. Others, aware of the increase in severity of infections which may result, and which may reduce the effectiveness of antimicrobial therapy, have felt that the risk is unwarranted, unnecessary, and only rarely justified, and that the few unfavourable results may more than balance any temporary and apparent advantages. The middle course is taken by those who, recognizing the dangers, have limited the use of the hormone treatment to the first day or two while antibiotics are being given, in the hope of obtaining the maximum benefits from the hormones while incurring a minimum of risks from their use.
There is general agreement that in experimental infections cortisone and A.C.T.H. enhance infections of almost all types. It is also clear that this enhancement of infection or decrease in resistance to infection is quite non-specific with respect to the microbial aetiology of the disease and is even independent of multiplication of the organisms themselves, since it can be demonstrated in the increase in necrotic action of bacterial toxins alone. There is also abundant evidence that many types of human infections are aggravated by treatment with A.C.T.H. and cortisone, and that such treatment also gives rise to spontaneous infections with organisms that are normally saprophytic, or renders clinically active other infections which may be latent. This enhancement of infection, however, is associated with certain non-specific alterations in the clinical manifestations of infection which include a drop in temperature and increase in the general appearance of well-being which are known to be the direct results of hormone therapy and which occur in spite of advancing infections. These non-specific effects make it difficult and sometimes impossible to evaluate the course of the infection or to recognize the occurrence of new and complicating infections. 
Prophylaxis
There is little doubt that, in the U.S.A. at least, the total volume of antimicrobial agents used in prophylaxis or for minor and irrelevant indications exceeds by manyfold the total amount used in the treatment of infections for which they are specifically indicated. In the recent report on the use of one agent at a large community and teaching hospital it was revealed that 650% of the patients received that agent solely for propliylaxis, and many of the same patients had been given other antibiotics at the same time. It is obviously impossible to evaluate such usage. A few words concerning some of the more specifically directed prophylactic uses of antimicrobial agents may be in order.
In evaluating prophylaxis it is desirable to know, first, the objective and how that can best be measured; second, the best method of accomplishing that objective; and, third, the price that must be paid, not particularly in dollars and cents, but in terms of serious side-effects. As to the objectives, one may differentiate several types of uses.
(1) Mass pr-ophylaxis of short duration and for a specific purpose, as in the use of sulphadiazine in the elimination of meningococcal infections and carriers.
(2) Mass prophylaxis on a continuous basis, as in the attempt to minimize acute respiratory infections through the administration of sulphadiazine.
(3) Individual prophylaxis on a continuous basis, as in the uise of sulphonamides or penicillin in the prevention of recurrences of rheumatic fever indirectly through the prevention of haemolytic streptococcal infections.
(4) Individual but brief prophylaxis against specific infections.
as in the use of oral penicillin followinig venereal exposures or perhaps in the prevention of ophthalmia neonatorum.
(5) Individual prophylaxis, given in a more prolonged or intensive course, in the hope of preventing various infections, as in the use of antimicrobial agents: (a) in the preparation for bowel resections or immediately after such resections; (b) in women during or after long and complicated delivery; (c) after catheterization or instrumentation of the urinary tract, or after operations in this region; (d) in relation to tooth extraction or dental manipulations in patients with valvular or congenital cardiac defects in the hope of preventing subacute bacterial endocarditis; and (e) during the early phases of management of burns and other potentially infected surface wounds.
The use of antibiotics in the treatment of common colds and acute simple undifferentiated respiratory diseases or in non-streptococcal pharyngitis may perhaps also be included in the latter category because this amounts essentially to the prophylaxis of complicating bacterial infections. On the other hand, early treatment of streptococcal infections as a means of preventing attacks of rheumatic fever or glomerulonephritis may be considered in a different category, since one is here dealing with an already established infection for which one is administering specific -treatment.
The different types of prophylactic uses do not lend themselves equally to proper evaluation. From available data, however, one may easily conclude that the two most successful of these uses have been the mass prophylaxis of meningococcal infections by the administration of a short course of sulphadiazine and the individual prophylaxis of gonococcal infections by the use of single oral doses of penicillin immediately following exposure. The success of these procedures is based on the fact that in these situations one is dealing with specific bacteria against which the prophylactic agents have proved efficacy to a marked degree under the particular conditions in which they are used. Moreover, under these conditions the untoward effects are minimal.
The success of individual prophylaxis of streptococcal infections and recrudescences of rheumatic fever by continuous administration of sulphonamides or penicillin is more difficult to measure, but seems fairly well established. Although this involves a greater risk of untoward effects, that seems warranted in view of the nature of the disease one aims to prevent. In this connexion it may be pointed out that the choice of the optimum agent has not been clearly defined. It may therefore be worth considering that, although penicillin may be slightly more effective for the purpose, it may still be preferable to use another agent, like a sulphonamide, which is adequate for the purpose. Should an infection then occur it is less likely to be resistant to penicillin, which would then be available, and more likely to be effective in the treatment of that infection.
Mass prophylaxis on a continuous basis has been only partially successful, but for the purpose for which it was designed it has served as well as was possible at the time. Such continuous prophylaxis is inevitably accompanied by a much greater risk of untoward effects, some of which may be serious. The experiences with such usage in the U.S. Armed Forces during the second world war taught us the danger of the replacement of the prevalent flora by organisms resistant to the prophylactic agent being used. This phenomenon has more clearly been exemplified, on a different scale and under different circumstances, by the spread of penicillin-resistant staph\ lococci in hospitals where they are widely and continuously used.
In the experience with sulphadiazine prophylaxis during the second world war it was fortunate that the severe infections with sulphadiazine-resistant streptococci occurred just at a time when penicillin became available, so that the potentially serious consequence of the fact that sulphadiazine was no longer effective in these cases was mitigated by the use of penicillin. This emphasizes the importance of choosing for prophylaxis an agent which is effective, but which is different from the one that must be relied on for the treatment of severe infections that may arise during such prophylaxis. Individual prophylaxis for specific purposes is of course the major excuse for the widespread use of antibiotics. It is also the most difficult to evaluate. No attempt will be made to do so, but a brief comment on one of the more accepted uses which is considered to be fully justified may be in order-namely, the use of penicillin during dental manipulations in patients with valvular or congenital heart disease for the prevention of bacterial endocarditis. Although the principle of this usage is generally accepted, there is considerable difference of opinion regarding the dosage to be used, whether it is necessary to give the antibiotic before the actual procedure, for how long before and for how long after that procedure. The controversies may stem from the fact that the objective is not entirely clear. For example, if the aim is to eliminate the potential bloodstream invaders from the dental foci it would require large doses given over a long period prior to the dental procedures; only a brief period of treatment would then be required after the actual operation, unless one were dealing with an infection which had not been entirely eradicated at the time, when resort must be had to more prolonged use of similar large doses. On the other hand, if the aim is merely to clear the blood stream of the organisms which invade just at the time of the dental procedure, a single relatively small dose given at or shortly before that time should suffice.
Obviously one cannot hope to prevent all blood-stream invasions from dental foci, since presumably such invasion takes place during inevitable daily procedures, such as the mastication of food and the brushing of teeth. If one should wish to prevent or to minimize the dangers of such invasions one might be tempted to use continuous therapy throughout the life of the individual. Of the extremes that have been advocated, the use of the single small dose reduces or prevents the immediate bacteriaemia and is obviously associated with the least risk of sensitization and other reactions, and also offers the smallest risk of replacing the oral or dental flora by the potential causative organisms of endocarditis, which may be resistant to penicillin, whereas the more prolonged treatment with the largest doses offers the greatest potential risks in these respects, although it may best serve the purpose of reducing or eliminating dental infections.
The final answer to this problem cannot be given, for there seems to be no acceptable evidence that any cases of bacterial endocarditis have actually been prevented by any type of prophylaxis. On the other hand, there are at least a few cases of bacterial endocarditis, fairly well authenticated, which have followed extractions under prophylaxis of various types. Of particular interest is the fact that in the patient who received the largest doses and for the longest period the endocarditis which fol'owed was caused by the most resistant organism. Here is further support for the general idea that the prophylactic agent of choice for any given purpose should be different from the one on which it may be necessary later to place chief reliance for cure of infections that might occur. Put another way, a less active agent may suffice for prophylactic purposes but may not prove adequate for treatment, should that become necessary.
Omnibiotics
The physician in practice, and many of his patients as well, are constantly on the look-out for some simple substance or formula which can be applied with universal success. The busy practitioner is particularly desirous of having some major weapon on which he can always rely to be successful in all types of infections, and which would thus relieve him of the responsibility and trouble involved in the complicated or even simple diagnostic procedures.
Whenever such a cure-all has been 'offered it has usually been grasped with enthusiasm and widely and indiscriminately applied. The disappointment which invariably has followed has always been proportional to the magnitude of the unwarranted promises and claims that had been held out. On the other hand, the discriminate choice of therapeutic agents only on the basis of proper indication and proved efficacy for the desired purpose, though perhaps more difficult to practise, may in the long run be less disappointing and more rewarding.
Summary and Conclusions
This has been an attempt to bring out in a critical manner some of the current problems in the use of the antibiotics at present available. Many of the opinions that have been expressed will undoubtedly meet with honest and justifiable disagreement, for they express only the deductions made by me on the basis of my own experience. There is one conclusion, however, with which few will dissent-namely, that there still remain many problems in the treatment and prevention of infectious diseases which have not been solved by the antibiotics at present available.
